DACARBAZINE Gene Set

Dataset DGIdb Drug Targets 2026
Category physical interactions
Type drug
Description A monocarboxylic acid amide that is 1H-imidazole-4-carboxamide which is substituted at position 5 by a 3,3-dimethyltriaz-1-en-1-yl group. It is used for the treatment of metastatic malignant melanoma, and in combination with other drugs for the treatment of Hodgkin's disease and soft-tissue sarcoma. (Chemical Entities of Biological Interest Ontology, CHEBI_4305)
External Link https://dgidb.org/results?searchType=drug&searchTerms=DACARBAZINE
Similar Terms
Downloads & Tools

Genes

15 interacting proteins for the DACARBAZINE drug from theDGIdb Drug Targets 2026 dataset.

Symbol Name Standardized Value
EPM2AIP1 EPM2A (laforin) interacting protein 1 3.5288
POLA2 polymerase (DNA directed), alpha 2, accessory subunit 1.00823
ADK adenosine kinase 0.6416
FN1 fibronectin 1 0.6416
GSTM1 glutathione S-transferase mu 1 0.306852
MGMT O-6-methylguanine-DNA methyltransferase 0.213867
CYP1A1 cytochrome P450, family 1, subfamily A, polypeptide 1 0.185726
PLAU plasminogen activator, urokinase 0.150162
BAX BCL2-associated X protein 0.106933
CXCL8 chemokine (C-X-C motif) ligand 8 0.04411
CYP1A2 cytochrome P450, family 1, subfamily A, polypeptide 2 0.0241699
CYP2C9 cytochrome P450, family 2, subfamily C, polypeptide 9 0.0161872
CYP2C19 cytochrome P450, family 2, subfamily C, polypeptide 19 0.0147958
CYP2D6 cytochrome P450, family 2, subfamily D, polypeptide 6 0.0115509
CYP3A4 cytochrome P450, family 3, subfamily A, polypeptide 4 0.00796569